Clinical experience with titanium mesh in reconstruction of massive chest wall defects following oncological resection

Por Yang, Haitang, Tantai, Jicheng, Zhao, Heng
Publicado no J Thorac Dis (2015)

Single-stage bilateral pulmonary resections by video-assisted thoracic surgery for multiple small nodules

Por Yao, Feng, Yang, Haitang, Zhao, Heng
Publicado no J Thorac Dis (2016)

Clinical outcomes of surgery after induction treatment in patients with pathologically proven N2-positive stage III non-small cell lung cancer

Por Yang, Haitang, Yao, Feng, Zhao, Yang, Zhao, Heng
Publicado no J Thorac Dis (2015)

Survival prognostic factors for patients with synchronous brain oligometastatic non-small-cell lung carcinoma receiving local therapy

Por Bai, Hao, Xu, Jianlin, Yang, Haitang, Jin, Bo, Lou, Yuqing, Wu, Dan, Han, Baohui
Publicado no Onco Targets Ther (2016)

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

Por Fan, Liwen, Yang, Haitang, Yao, Feng, Zhao, Yang, Gu, Haiyong, Han, Ke, Zhao, Heng
Publicado no Onco Targets Ther (2017)

Clinical outcomes of surgically resected combined small cell lung cancer: a two-institutional experience

Por Zhang, Chao, Yang, Haitang, Zhao, Heng, Lang, Baoping, Yu, Xiangdong, Xiao, Peng, Zhang, Xiao
Publicado no J Thorac Dis (2017)

Clinical outcomes of patients with metachronous second primary lung adenocarcinomas

Por Zhao, Heng, Yang, Haitang, Han, Ke, Xu, Jianlin, Yao, Feng, Zhao, Yang, Fan, Liwen, Gu, Haiyong, Shen, Zhenya
Publicado no Onco Targets Ther (2017)

Comparison of outcomes of tyrosine kinase inhibitor in first- or second-line therapy for advanced non-small-cell lung cancer patients with sensitive EGFR mutations

Por Xu, Jianlin, Zhang, Xueyan, Yang, Haitang, Ding, Guozheng, Jin, Bo, Lou, Yuqing, Zhang, Yanwei, Wang, Huimin, Han, Baohui
Publicado no Oncotarget (2016)

EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation

Por Xu, Jianlin, Yang, Haitang, Jin, Bo, Lou, Yuqing, Zhang, Yanwei, Zhang, Xueyan, Zhong, Hua, Wang, Huiming, Wu, Dan, Han, Baohui
Publicado no Sci Rep (2016)

Corrigendum: EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation

Por Xu, Jianlin, Yang, Haitang, Jin, Bo, Lou, Yuqing, Zhang, Yanwei, Zhang, Xueyan, Zhong, Hua, Wang, Huiming, Wu, Dan, Han, Baohui
Publicado no Sci Rep (2016)

Reconstruction of mediastinal vessels for invasive thymoma: a retrospective analysis of 25 cases

Por Sun, Yifeng, Gu, Chang, Shi, Jianxin, Fang, Wentao, Luo, Qingquan, Hu, Dingzhong, Fu, Shijie, Pan, Xufeng, Chen, Yong, Yang, Yu, Yang, Haitang, Zhao, Heng, Chen, Haiquan
Publicado no J Thorac Dis (2017)